José Valentín
García Gutiérrez
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitari de Bellvitge (17)
2024
-
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
Leukemia
-
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
Annals of Hematology, Vol. 103, Núm. 11, pp. 4537-4544
-
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Leukemia
2023
2022
-
Breakthrough infections in MPN-COVID vaccinated patients
Blood Cancer Journal
-
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
Annals of Hematology, Vol. 101, Núm. 10, pp. 2231-2239
-
Second versus first wave of COVID-19 in patients with MPN
Leukemia
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
2021
-
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Blood Cancer Journal, Vol. 11, Núm. 2
-
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
Leukemia, Vol. 35, Núm. 2, pp. 485-493
-
Long-term follow-up of recovered MPN patients with COVID-19
Blood Cancer Journal
-
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy
Biochemical Pharmacology, Vol. 192
2020
-
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 12, pp. 2237-2244
2018
-
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia
British Journal of Haematology
-
Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis
Leukemia
-
Prognostic risk models for transplant decision-making in myelofibrosis
Annals of Hematology, Vol. 97, Núm. 5, pp. 813-820
2017
-
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea
Haematologica, Vol. 102, Núm. 1, pp. 103-109